A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

July 20, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Overweight or ObesityCKDType 2 Diabetes
Interventions
DRUG

Retatrutide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (42)

11501

NYU Langone Hospital - Long Island, Mineola

20132

Ospedale San Raffaele, Milan

20138

Centro Cardiologico Monzino, Milan

24127

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo

33511

Teradan Clinical Trials, LLC, Brandon

34652

Suncoast Clinical Research, Inc., New Port Richey

39069

Prime Health and Wellness/SKYCRNG, Fayette

41003

Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE), Seville

44195

Cleveland Clinic, Cleveland

46010

Hospital Clinico de Valencia, Valencia

46017

Hospital Universitario Doctor Peset, Valencia

46202

Indiana University Health University Hospital, Indianapolis

56126

Azienda Ospedaliera Universitaria Pisana, Pisa

60640

Great Lakes Clinical Trials - Ravenswood, Chicago

77024

Victorium Clinical Research - Houston, Houston

77079

Endocrine Ips, Pllc, Houston

77598

Tranquility Research, Webster

80045

University of Colorado Anschutz Medical Campus, Aurora

85206

Care Access - 801 South Power Road, Mesa, Mesa

85225

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler

85260

Headlands Research - Scottsdale, Scottsdale

85283

Medical Advancement Centers of Arizona, Tempe

89128

Palm Research Center Tenaya, Las Vegas

90274

Peninsula Research Associates, Rolling Hills Estates

91303

Hope Clinical Research, Inc., Canoga Park

91763

Catalina Research Institute, LLC, Montclair

L6S 0C6

Centricity Research Brampton Endocrinology, Brampton

L7M 1K9

Circulate Cardiac & Vascular Centre, Burlington

M6B 3H7

North York Diagnostic and Cardiac Centre, North York

L4A 1H2

Stouffville Medical Research Institute Inc., Stouffville

M9V 4B4

Dr. Anil K. Gupta Medicine Professional Corporation, Toronto

N2J 1C4

Fadia El Boreky Medicine, Waterloo

J4V 2G8

Viacar Recherche Clinique, Greenfield Park

J6E 6A9

Diex Recherche Joliette, Joliette

H4N 2W2

9109-0126 Quebec Inc., Montreal

CB2 2QQ

Addenbrooke's Hospital, Cambridge

TS19 8PE

FutureMeds Teesside - Middlefield Centre, Stockton-on-Tees

E1 1BB

Royal London Hospital, London

Unknown

Futuremeds-Newcastle, Newcastle

M6 8HD

Vascular Research Team, Salford

N18 1QX

North Middlesex Hospital, London

NG5 1PB

City Hospital, Nottingham University Hospitals NHS Trust, Nottingham

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY